UCB's Global Corporate Website

UCB marks International Epilepsy Day

Posted by
Mike Davis, Seizure Freedom Patient Value Mission
08-Feb-2016
Monday, 8 February, is International Epilepsy Day – a time to acknowledge the huge impact the disease has and the positive effect of seizure control on the lives of those affected.

An estimated 65 million people have epilepsy worldwide. Around half of newly-diagnosed patients are seizure-free with their first anti-epileptic drug.

However, one third of people with epilepsy live with uncontrolled seizures despite having tried over three medications.

Each year on the second Monday of February people join together to bring awareness to the impact of epilepsy on those living with the condition, as well as their families and carers.

This year, International Epilepsy Day, which is a joint initiative by the International Bureau for Epilepsy (IBE) and the International League Against Epilepsy (ILAE), will focus on public education.

As the recurring theme of International Epilepsy Day suggests, improving the lives of people with epilepsy is about ‘more than seizures’.

Some of the best entries from a photography competition entitled Yes I can will be on display at the European Parliament in Strasbourg – helping to put the issue of epilepsy care and research on the political agenda.

At UCB, we support the epilepsy community by focusing on three key areas:
  • Unlocking the match of the right solution for the right patient at the right time
  • Decreasing the time to seizure control and 
  • Addressing the current gap in solutions for patients.
With an outside-in approach to deepen our understanding of the lived experience with epilepsy and to co-create solutions together with patients, UCB aims to partner with patients along the journey to seizure freedom.

Visit our Epilepsy section

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.

CAPTCHA

Enter the characters shown in the image.